Overall, it honestly tasted just like strawberry lemonade. What Testers Think Could Be Improved Although the product dissolved quickly, in about 10 seconds, our tester noticed some settling of the powder at the bottom of the bottle
In the drugs best showing so far, the ATTAIN-1 trial, people taking orforglipron lost on average 12.4% of their baseline weight, a notch below the roughly 14% weight loss seen in similar trials of Novo Nordisks injectable Wegovy and also below the typical results seen with Eli Lillys tirzepatide, a dual GLP-1/GIP medication
With Foundayo, we now have an oral option that delivered an average of 12.4% weight loss at the highest dose in clinical trials addressing both the clinical realities of obesity and the practical challenges patients face every day, Horn noted
NICE guidelines (NG28) recommend specific injectable GLP-1 receptor agonists for type 2 diabetes management in appropriate clinical contexts
GLP-1 Up supports your bodys natural GLP-1 production the hormone that helps regulate appetite, blood sugar, and energy
.png)
